343
Views
17
CrossRef citations to date
0
Altmetric
Review

Advances in stem cell therapy for erectile dysfunction

, , &
Pages 1137-1150 | Received 13 Jun 2018, Accepted 08 Oct 2018, Published online: 21 Oct 2018

References

  • Skeldon SC, Cheng L, Morgan SG, et al. Erectile dysfunction medications and treatment for cardiometabolic risk factors: a pharmacoepidemiologic study. J Sex Med. 2017;14(12):1597–1605.
  • Korenman SG. Epidemiology of erectile dysfunction. Endocrine. 2004;23(2–3):87–91.
  • Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.
  • Shin D, Pregenzer G Jr., Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19(1):5–11.
  • Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med. 2013;10(1):195–203.
  • Zhang H, Zheng W, Shen Y, et al. Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse ovaries. Proc Natl Acad Sci U S A. 2012;109(31):12580–12585.
  • Morizono K, De Ugarte DA, Zhu M, et al. Multilineage cells from adipose tissue as gene delivery vehicles. Hum Gene Ther. 2003;14(1):59–66.
  • Albersen M, Kendirci M, Van der Aa F, et al. Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med. 2012;9(2):385–403.
  • De Berardis G, Franciosi M, Belfiglio M. et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care. 2002;25(2):284–291.
  • Burke JP, Jacobson DJ, McGree ME, et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol. 2007;177(4):1438–1442.
  • Wang L, Tian W, Uwais Z, et al. AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats. J Sex Med. 2014;11(6):1452–1462.
  • Usta MF, Bivalacqua TJ, Koksal IT, et al. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment. BJU Int. 2004;94(3):429–432.
  • Yohannes E, Chang J, Tar MT, et al. Molecular targets for diabetes mellitus-associated erectile dysfunction. Mol Cell Proteomics. 2010;9(3):565–578.
  • Tarhan F, Demirel GY, Kuyumcuoğlu U, et al. Apoptosis of corpus cavernosum in patients with organic erectile dysfunction. World J Urol. 2009;27(2):235–240.
  • Tousoulis D, Tsarpalis K, Cokkinos D, et al. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications. Diabetes Obes Metab. 2008;10(10):834–842.
  • Jansson PA. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med. 2007;262(2):173–183.
  • Bahk JY, Jung JH, Han H, et al. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant. 2010;8(2):150–160.
  • Skakun NP, Shman’ko VV. Antioxidant effectiveness in isoniazid-induced lesions of the liver. Farmakol Toksikol. 1986;49(4):86–89.
  • Qiu X, Sun C, Yu W, et al. Combined strategy of mesenchymal stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes-associated erectile dysfunction. J Androl. 2012;33(1):37–44.
  • Sun C, Lin H, Yu W, et al. Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats. Int J Androl. 2012;35(4):601–607.
  • Qiu X-F, Li -X-X, Chen Y, et al. Mobilisation of endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing erectile dysfunction in diabetic rats. Asian J Androl. 2012;14(3):481–486.
  • Nishimatsu H, Suzuki E, Kumano S, et al. Adrenomedullin mediates adipose tissue-derived stem cell-induced restoration of erectile function in diabetic rats. J Sex Med. 2012;9(2):482–493.
  • Gou X, He W-Y, Xiao M-Z, et al. Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats. Asian J Androl. 2011;13(2):332–338.
  • Liu G, Sun X, Bian J, et al. Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One. 2013;8(8):e72790.
  • Qiu X, Lin G, Xin Z, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013;10(3):738–746.
  • Zhou F, Hui Y, Xu Y, et al. Effects of adipose-derived stem cells plus insulin on erectile function in streptozotocin-induced diabetic rats. Int Urol Nephrol. 2016;48(5):657–669.
  • Ryu J-K, Kim D-H, Song K-M, et al. Intracavernous delivery of clonal mesenchymal stem cells rescues erectile function in the streptozotocin-induced diabetic mouse. Andrology. 2016;4(1):172–184.
  • Long X, Tharp DL, Georger MA, et al. The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem. 2009;284(48):33671–33682.
  • Salkoff L, Butler A, Ferreira G, et al. High-conductance potassium channels of the SLO family. Nat Rev Neurosci. 2006;7(12):921–931.
  • He Y, He W, Qin G, et al. Transplantation KCNMA1 modified bone marrow-mesenchymal stem cell therapy for diabetes mellitus-induced erectile dysfunction. Andrologia. 2014;46(5):479–486.
  • Ouyang B, Sun X, Han D, et al. Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model. PLoS One. 2014;9(3):e92825.
  • Liu T, Peng Y, Jia C, et al. Hepatocyte growth factor-modified adipose tissue-derived stem cells improve erectile function in streptozotocin-induced diabetic rats. Growth Factors. 2015;33(4):282–289.
  • Garcia MM, Fandel TM, Lin G, et al. Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med. 2010;7(1 Pt 1):89–98.
  • Kovanecz I, Vernet D, Masouminia M, et al. Implanted muscle-derived stem cells ameliorate erectile dysfunction in a rat model of type 2 diabetes, but their repair capacity is impaired by their prior exposure to the diabetic milieu. J Sex Med. 2016;13(5):786–797.
  • Lu J, Xin Z, Zhang Q, et al. Beneficial effect of PEDF-transfected ADSCs on erectile dysfunction in a streptozotocin-diabetic rat model. Cell Tissue Res. 2016;366(3):623–637.
  • Shan H-T, Zhang H-B, Chen W-T, et al. Combination of low-energy shock-wave therapy and bone marrow mesenchymal stem cell transplantation to improve the erectile function of diabetic rats. Asian J Androl. 2017;19(1):26–33.
  • Zhu -L-L, Zhang Z, Jiang H-S, et al. Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction. Asian J Androl. 2017;19(4):425–432.
  • Chen F, Zhang H, Wang Z, et al. Adipose-derived stem cell-derived exosomes ameliorate erectile dysfunction in a rat model of type 2 diabetes. J Sex Med. 2017;14(9):1084–1094.
  • Cengiz T, Kaya E, Oral DY, et al. Intracavernous injection of human umbilical cord blood mononuclear cells improves erectile dysfunction in streptozotocin-induced diabetic rats. J Sex Med. 2017;14(1):50–58.
  • Capogrosso P, Montorsi F, Salonia A. Phase I and phase II clinical trials for the treatment of male sexual dysfunction-a systematic review of the literature. Expert Opin Investig Drugs. 2018;27(7):583–593.
  • Al Demour S, Jafar H, Adwan S, et al. Safety and potential therapeutic effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in diabetic patients with erectile dysfunction: an open label phase I clinical trial. Urol Int. 2018;1–8.
  • Li M, Page P, Li L, et al. Stem cell therapy for diabetic erectile dysfunction in rats: a meta-analysis. PLoS One. 2016;11(4):e0154341.
  • Namiki M, Akaza H, Lee SE, et al. Prostate cancer working group report. Jpn J Clin Oncol. 2010;40(Suppl 1):i70–75.
  • Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59(1):61–71.
  • McCullough AR. Sexual dysfunction after radical prostatectomy. Rev Urol. 2005;7(Suppl 2):S3–S10.
  • Lin G, Banie L, Ning H, et al. Potential of adipose-derived stem cells for treatment of erectile dysfunction. J Sex Med. 2009;6 Suppl 3(Suppl 3):320–327.
  • Hatzimouratidis K, Burnett AL, Hatzichristou D, et al. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol. 2009;55(2):334–347.
  • Kendirci M, Hellstrom WJG. Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer. 2004;3(2):87–92.
  • Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55(5):1037–1063.
  • Ficarra V, Novara G, Ahlering TE, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):418–430.
  • Peak TC, Anaissie J, Hellstrom WJG. Current perspectives on stem cell therapy for erectile dysfunction. Sex Med Rev. 2016;4(3):247–256.
  • Mangır N, Türkeri L. Stem cell therapies in post-prostatectomy erectile dysfunction: a critical review. Can J Urol. 2017;24(1):8609–8619.
  • Bochinski D, Lin GT, Nunes L, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004;94(6):904–909.
  • Lin C-S, Xin Z-C, Wang Z, et al. Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev. 2012;21(3):343–351.
  • Alwaal A, Zaid UB, Lin C-S, et al. Stem cell treatment of erectile dysfunction. Adv Drug Deliv Rev. 2015;82–83:137–144.
  • Santiago LY, Clavijo-Alvarez J, Brayfield C, et al. Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant. 2009;18(2):145–158.
  • Zhang Y, Luo H, Zhang Z, et al. A nerve graft constructed with xenogeneic acellular nerve matrix and autologous adipose-derived mesenchymal stem cells. Biomaterials. 2010;31(20):5312–5324.
  • Albersen M, Fandel TM, Lin G, et al. Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med. 2010;7(10):3331–3340.
  • Kendirci M, Trost L, Bakondi B, et al. Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury. J Urol. 2010;184(4):1560–1566.
  • Kim SJ, Park SH, Sung YC, et al. Effect of mesenchymal stem cells associated to matrixen on the erectile function in the rat model with bilateral cavernous nerve crushing injury. Int Braz J Urol. 2012;38(6):833–841.
  • Qiu X, Fandel TM, Ferretti L, et al. Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury. Eur Urol. 2012;62(4):720–727.
  • Kim SJ, Choi SW, Hur KJ, et al. Synergistic effect of mesenchymal stem cells infected with recombinant adenovirus expressing human BDNF on erectile function in a rat model of cavernous nerve injury. Korean J Urol. 2012;53(10):726–732.
  • You D, Jang MJ, Lee J, et al. Periprostatic implantation of human bone marrow-derived mesenchymal stem cells potentiates recovery of erectile function by intracavernosal injection in a rat model of cavernous nerve injury. Urology. 2013;81(1):104–110.
  • Jeong HH, Piao S, Ha JN, et al. Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)/brain-derived neurotrophic factor (BDNF)-membrane system in a rat model of cavernous nerve injury. Urology. 2013;81(5):1108 e7–14.
  • You D, Jang MJ, Lee J, et al. Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Prostate. 2013;73(3):278–286.
  • Miyamoto K, Inoue S, Kobayashi K, et al. Rat cavernous nerve reconstruction with CD133+ cells derived from human bone marrow. J Sex Med. 2014;11(5):1148–1158.
  • Song K-M, Jin H-R, Park J-M, et al. Intracavernous delivery of stromal vascular fraction restores erectile function through production of angiogenic factors in a mouse model of cavernous nerve injury. J Sex Med. 2014;11(8):1962–1973.
  • Ying C, Hu W, Cheng B, et al. Erectile function restoration after repair of resected cavernous nerves by adipose-derived stem cells combined with autologous vein graft in rats. Cell Mol Neurobiol. 2014;34(3):393–402.
  • Xu Y, Guan R, Lei H, et al. Therapeutic potential of adipose-derived stem cells-based micro-tissues in a rat model of postprostatectomy erectile dysfunction. J Sex Med. 2014;11(10):2439–2448.
  • Kim JH, Lee HJ, Doo SH, et al. Use of nanoparticles to monitor human mesenchymal stem cells transplanted into penile cavernosum of rats with erectile dysfunction. Korean J Urol. 2015;56(4):280–287.
  • Yang R, Fang F, Wang J, et al. Adipose-derived stem cells ameliorate erectile dysfunction after cavernous nerve cryoinjury. Andrology. 2015;3(4):694–701.
  • You D, Jang MJ, Kim BH, et al. Comparative study of autologous stromal vascular fraction and adipose-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Stem Cells Transl Med. 2015;4(4):351–358.
  • Song L, Zhu J, Zhang X, et al. BDNF-hypersecreting human umbilical cord blood mesenchymal stem cells promote erectile function in a rat model of cavernous nerve electrocautery injury. Int Urol Nephrol. 2016;48(1):37–45.
  • Gokce A, Peak TC, Abdel-Mageed AB, et al. Adipose tissue-derived stem cells for the treatment of erectile dysfunction. Curr Urol Rep. 2016;17(2):14.
  • Yiou R. Hamidou L, Birebent B, et al. Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: an open dose-escalation pilot study. Eur Urol. 2016;69(6):988–991.
  • Haahr MK, Jensen CH, Toyserkani NM, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase i clinical trial. EBioMedicine. 2016;5:204–210.
  • Jeon SH, Shrestha KR, Kim RY, et al. Combination therapy using human adipose-derived stem cells on the cavernous nerve and low-energy shockwaves on the corpus cavernosum in a rat model of post-prostatectomy erectile dysfunction. Urology. 2016;88(p. 226):e1–9.
  • Lin H, Dhanani N, Tseng H, et al. Nanoparticle improved stem cell therapy for erectile dysfunction in a rat model of cavernous nerve injury. J Urol. 2016;195(3):788–795.
  • Filleur S, Nelius T, de Riese W, et al. Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem. 2009;106(5):769–775.
  • Tombran-Tink J, Johnson LV. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci. 1989;30(8):1700–1707.
  • Chen X, Jiang M, Duan D, et al. Neurotrophic effect of adipose tissue-derived stem cells on erectile function recovery by pigment epithelium-derived factor secretion in a rat model of cavernous nerve injury. Stem Cells Int. 2016;2016:5161248.
  • Yang Q, Chen X, Zheng T, et al. Transplantation of human urine-derived stem cells transfected with pigment epithelium-derived factor to protect erectile function in a rat model of cavernous nerve injury. Cell Transplant. 2016;25(11):1987–2001.
  • You D, Jang MJ, Kim BH, et al. Bone marrow-derived mesenchymal stromal cell therapy in a rat model of cavernous nerve injury: preclinical study for approval. Cytotherapy. 2016;18(7):870–880.
  • Fandel TM, Albersen M, Lin G, et al. Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol. 2012;61(1):201–210.
  • Martínez-Salamanca JI, Zurita M, Costa C, et al. Dual strategy with oral phosphodiesterase type 5 inhibition and intracavernosal implantation of mesenchymal stem cells is superior to individual approaches in the recovery of erectile and cavernosal functions after cavernous nerve injury in rats. J Sex Med. 2016;13(1):1–11.
  • Soebadi MA, Milenkovic U, Weyne E, et al. Stem cells in male sexual dysfunction: are we getting somewhere? Sex Med Rev. 2017;5(2):222–235.
  • Zhu LL, Huang X, Yu W et al. Transplantation of adipose tissue-derived stem cell-derived exosomes ameliorates erectile function in diabetic rats. Andrologia. 2018;50(2.
  • Haahr MK, Jensen CH, Toyserkani NM, et al. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. Urology. 2018.
  • Saigal CS, Wessells H, Pace J, et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207–212.
  • Laumann EO, West S, Glasser D, et al. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med. 2007;4(1):57–65.
  • Costa WS, Carrerete FB, Horta WG et al. Comparative analysis of the penis corpora cavernosa in controls and patients with erectile dysfunction. BJU Int. 2006;97(3):567–569.
  • Nolazco G, Kovanecz I, Vernet D, et al. Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int. 2008;101(9):1156–1164.
  • Bivalacqua TJ, Deng W, Kendirci M, et al. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol. 2007;292(3):H1278–90.
  • Abdel Aziz MT, El-Haggar S, Mostafa T, et al. Effect of mesenchymal stem cell penile transplantation on erectile signaling of aged rats. Andrologia. 2010;42(3):187–192.
  • Lin G, Reed-Maldonado AB, Wang B, et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. J Sex Med. 2017;14(4):493–501.
  • Yang J, Zhang Y, Zang G, et al. Adipose-derived stem cells improve erectile function partially through the secretion of IGF-1, bFGF, and VEGF in aged rats. Andrology. 2018;6(3):498–509.
  • Carmona JJ, Michan S. Biology of healthy aging and longevity. Rev Invest Clin. 2016;68(1):7–16.
  • Garaffa G, Trost LW, Serefoglu EC, et al. Understanding the course of Peyronie’s disease. Int J Clin Pract. 2013;67(8):781–788.
  • Culha M, Alici B, Acar O, et al. The relationship between diabetes mellitus, impotence and veno-occlusive dysfunction in Peyronie’s disease patients. Urol Int. 1998;60(2):101–104.
  • Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie’s disease. J Urol. 1993;149(1):53–55.
  • Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie’s disease. Nat Clin Pract Urol. 2005;2(6):291–297.
  • Devine CJ Jr. International conference on Peyronie’s disease advances in basic and clinical research. March 17–19, 1993. Introduction. J Urol. 1997;157(1):272–275.
  • Gonzalez-Cadavid NF, Magee TR, Ferrini M, et al. Gene expression in Peyronie’s disease. Int J Impot Res. 2002;14(5):361–374.
  • Tal R, Heck M, Teloken P, et al. Peyronie’s disease following radical prostatectomy: incidence and predictors. J Sex Med. 2010;7(3):1254–1261.
  • Vernet D, Nolazco G, Cantini L, et al. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease. Biol Reprod. 2005;73(6):1199–1210.
  • Castiglione F, Hedlund P, Van der Aa F, et al. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie’s disease. Eur Urol. 2013;63(3):551–560.
  • Ma L, Yang Y, Sikka SC, et al. Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci U S A. 2012;109(6):2090–2095.
  • Gokce A, Abd Elmageed ZY, Lasker GF, et al. Intratunical injection of genetically modified adipose tissue-derived stem cells with human interferon alpha-2b for treatment of erectile dysfunction in a rat model of tunica albugineal fibrosis. J Sex Med. 2015;12(7):1533–1544.
  • Wei X, Du Z, Zhao L, et al. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells. 2009;27(2):478–488.
  • Levy JA, Marchand M, Iorio L, et al. Effects of stem cell treatment in human patients with peyronie disease. J Am Osteopath Assoc. 2015;115(10):e8–13.
  • Song YS, Lee HJ, Park IH, et al. Human neural crest stem cells transplanted in rat penile corpus cavernosum to repair erectile dysfunction. BJU Int. 2008;102(2):220–224. discussion 224
  • Huang Y-C, Ning H, Shindel AW, et al. The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J Sex Med. 2010;7(4 Pt 1):1391–1400.
  • Qiu X, Villalta J, Ferretti L, et al. Effects of intravenous injection of adipose-derived stem cells in a rat model of radiation therapy-induced erectile dysfunction. J Sex Med. 2012;9(7):1834–1841.
  • Fatt M, Hsu K, He L, et al. Metformin acts on two different molecular pathways to enhance adult neural precursor proliferation/self-renewal and differentiation. Stem Cell Reports. 2015;5(6):988–995.
  • Goransson O, McBride A, Hawley SA, et al. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem. 2007;282(45):32549–32560.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.